Vascular thrombin receptor regulation in hypertensive rats

Circulation Research

Volumn 80, Issue 6, 1997, Pages 838-844

  Capers IV, Quinn ^a   Laursen, Jørn Bech ^a,c   Fukui, Toshiki ^a   Rajagopalan, Sanjay ^a   Mori, Ichiro ^a   Lou, Pingping ^a   Freeman, Brace A ^a   Berrington, William R ^a   Griendling, Kathy K ^a   Harrison, David G ^a,b   Runge, Marschall S ^a   Alexander, R Wayne ^a   Taylor, W Robert ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

angiotensin II; aorta; Dahl rat; hypertension; vascular smooth muscle

Indexed keywords

ANGIOTENSIN; COPPER ZINC SUPEROXIDE DISMUTASE; HYDRALAZINE; LOSARTAN; MESSENGER RNA; SUPEROXIDE; THROMBIN RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030966448     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.6.838     Document Type: Article

References (41)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
2. Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in treated essential hypertension. N Engl J Med. 1989;320:684-688.
3. Kannel WB. Implications of the primary prevention trials against coronary heart disease. J Hypertens Suppl. 1990;8:S245-S250.
4. Raftery EB. The metabolic effects of diuretics and other antihypertensive drugs: a perspective as of 1989. Int J Cardiol. 1990;28: 143-150.
5. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90:1614-1621.
6. Wilcox JN, Rodriguez J, Subramanian R, Ollerenshaw J, Zhong C, Hayzer DJ, Horaist C, Hanson SR, Lumsden A, Salam TA, Kelly AB, Harker LA, Runge MS. Characterization of thrombin receptor expression during vascular lesion formation. Circ Res. 1994;75: 1029-1038.
7. Bacchuber BG, Sarembock IJ, Gimple LW, McNamara CA, Owens GK. Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am J Physiol. 1995;268:C1141-C1147.
8. Kanthou C, Parry GW, Wijelath E, Kakkar VV, Demoliou-Mason C. Thrombin-induced proliferation and expression of PDGF-A chain in human vascular smooth muscle cells. FEBS Lett. 1992;314:143-148.
9. Weiss RH, Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem. 1993;268:5724-5727.
10. Haver VM, Namm DH. Generation of a vasoactive substance in human plasma during coagulation: evidence of thrombin-induced contraction of rabbit aorta and dog coronary artery. Blood Vessels. 1983;20:92-98.
11. Luscher TF, Richard V, Tschudi M, Yang ZH, Boulanger C. Endothelial control of vascular tone in large and small coronary arteries. J Am Coll Cardiol. 1990;15:519-527.
12. Ryan US, Shong R, Hayes BA, Visner G, Sauther ML. Regulation of endothelin-1 expression in normal and transfected endothelial cells. J Cardiovasc Pharmacol. 1993;22(suppl):S38-S41.
13. Wenzel UO, Fouqueray B, Grandaliano G, Kim Y-S, Karamitsos C, Valente AJ, Abboud HE. Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res. 1995;77:503-509.
14. Shankar R, de la Motte CA, Poptic EJ, DiCorleto PE. Thrombin receptor activating peptides differentially stimulate platelet-derived growth factor production, monocytic cell adhesion, and E-selectin expression in human umbilical vein endothelial cells. J Biol Chem. 1994;269:13506-13941.
15. +2] on human skin fibroblast growth and collagen production. J Dermatol Sci. 1990;1:325-333.
16. Bartha K, Brisson C, Archipoff G, de la Salle C, Lanza F, Cazenave JP, Beretz A. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem. 1993;268: 421-429.
17. Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, McGrath K. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost. 1993;70:469-474.
18. Vu TK, Jung DT, Wheaton VI, Cougblin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
19. Zhong C-H, Hayzer DH, Corson MA, Runge MS. Molecular cloning of the rat vascular smooth muscle thrombin receptor: evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem. 1992;267:16975-16979.
20. Capers Q IV, Laursen J, Griendling K, Berrington W, Freeman B, Alexander R, Taylor W. Redox-sensitive regulation of the vascular thrombin receptor in experimental hypertension and in cultured cells. Circulation. 1996;94(suppl I):I-33. Abstract.
21. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased to aortas from hypertensive rats. Circ Res. 1997;80:45-51.
22. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman B, Griendling K, Harrison D. Angiotensin II-mediated hypertension in the rat increases vascular Superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996;97: 1916-1923.
23. Rapp JP, McPartland RP, Sustarsic DL. A qualitative difference in plasma renin activity in Dahl rats susceptible or resistant to salt- induced hypertension. Biochem Genet. 1980;18:1087.
24. Pfeffer JD, Pfeffer MA, Frohlich ED. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med. 1971;78:957-962.
25. Schick BP, Eras J. Proteoglycans partially co-purify with RNA in TRI reagent and can be transferred to liters by Northern blotting. Biotechniques. 1995;18:574-576.
26. Howard AB, Alexander RW, Taylor WR. Effects of magnesium on nitric oxide synthase activity in endothelial cells. Am J Physiol. 1995;269:C612-C618.
27. Grandaliano G, Valente AJ, Abboud HE. A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein-1 production. J Exp Med. 1994;179:1737-1741.
28. Chobanian A. Corcoran lecture: adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1990; 15:666-674, Review.
29. Treasure CB, Klein JL, Vita JA, Manoukian SV, Renwich GH, Selwyn AP, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium- mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86-93.
30. Clozel M, Kuhn H, Hefti F, Baumgartner H. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18:132-141.
31. Todd M. Hypertensive structural changes in blood vessels: do endothelial cells hold the key? Can J Physiol Pharmacol. 1992;70: 536-551.
32. McVey JH. Tissue factor pathway. Baillieres Clin Hematol. 1994;7: 469-484.
33. Weiss HJ, Hoffman T, Turitto VT, Nemerson Y. Further studies on the presence of functional tissue factor on the subendothelium of normal human and rabbit arteries. Thromb Res. 1994;73: 313-326.
34. +2 mobilization and protein kinase C activation. J Clin Invest. 1993;91:547-552.
35. Giacomelli F, Anversa P, Wiener J. Effect of angiotensin-indueed hypertension on rat coronary arteries and myocardium. Am J Pathol. 1976;84:111-138.
36. Zoldhelyi P, Chesebro JH, Owen WG. Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig. Proc Natl Acad Sci U S A. 1993;90:1819-1823.
37. Horvat R, Palade GE. Thrombomodulin and thrombin localization on the vascular endothelium; their internalization and transcytosis by plasmalemmal vesicles. Eur J Cell Biol. 1993;61:299-313.
38. De Clerck F. Blood platelets in human essential hypertension. Agents Actions. 1986;18:563-580.
39. Teger-Nilsson AC, Larsson PT, Hjemdahl P, Olsson G. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease: potential effects of β-blockade. Circulation. 1991;84(suppl VI):VI-72-VI-77.
40. Vaughn DE, Laws SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: a potential link between the renin-angiotensin system and thrombosis. J Clin Invest. 1995;5:995-1001.
41. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE. Stimulation of plasminogen activator inhibitor-1 in vivo by infusion of angiotensin II: evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 1993;87:1969-1973.